KID31 and antibodies that bind thereto
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 20, 2012
Grant Date -
Jun 17, 2010
app pub date -
Feb 13, 2010
filing date -
Jan 12, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention provides the identification and characterization of a disease and cancer-associated antigen, KID31. The invention also provides modulators of KID31, including a family of monoclonal antibodies that bind to antigen KID31, and methods of diagnosing and treating various human cancers and diseases with KID31.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully